Financing Authority Sample Clauses

Financing Authority. The District Managing Board may obtain financing for any or all of the service facilities by any method authorized by law including, but not limited to the establishment of a tax base, the use of funds from a fund established under ORS 280.055 or ORS 451.540.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Financing Authority. Developer acknowledges and consents to the following: (i) the Agency continuing its practice to issue tax allocation debt through the Authority, a joint powers authority, to avoid having to issue bonds separately for each of its project areas; and (ii) if necessary or convenient, forming a separate joint powers authority to incur any of the Public Financing contemplated in this Financing Plan, with the Approval of Developer.
Sample 1Sample 2
Financing Authority. The estimated costs of the Project, including construction, engineering fees, acquisition of right-of-way and easements, contingencies and administrative expenses, are $709,960, with a portion of such costs anticipated to be paid by available grant moneys from the Kansas Department of Transportation. All or a portion of the costs of the Project, interest on interim financing and associated financing costs shall be payable from the proceeds of general obligation bonds of the City issued under authority of the Act (the “Bonds”).
Sample 1
Financing Authority. Attest: By: Xxx Xxxxx, Executive Director Xxxxx Xxxxxxxxxxx, Secretary THE LAND REFERRED TO HEREIN BELOW IS SITUATED IN THE CITY OF SOUTH LAKE TAHOE, COUNTY OF EL DORADO, STATE OF CALIFORNIA AND IS DESCRIBED AS FOLLOWS, TOGETHER WITH IMPROVEMENTS THEREON: Lot 41, as shown on the Official Map of Keller Park Subdivision, filed in the Office of the County Recorder of said County on July 19, 1951 in Map Book A, Map No. 202. Excepting therefrom the following: Beginning at the most Northerly corner of Lot 41 as shown and so delineated on that certain Map of Keller Park Subdivision, recorded in Map Book “A” at Page 102, Official Records of El Dorado County, California; thence from said point of beginning South 29°45’ East along the Northeasterly line of said Lot 41, 125.03 feet; thence leaving said line South 60°15’ West, 336.18 feet to a point on the Southwesterly line of said Lot 41; thence North 40°49’ West along said line 127.40 feet to the most Westerly corner of said Lot 41; thence North 60°15’ East along the Northwesterly line of said Lot 41; 360.63 feet to the point of beginning. Also excepting therefrom that portion conveyed to Xxxxxxxx X. Xxxxxx, in the instrument recorded October 6, 1972 in Book 1151 of Official Records, Page 262. Also excepting therefrom that portion conveyed to the City of South Lake Tahoe, in the instrument Recorded March 20, 1974 in Book 1252 of Official Records, Page 185. PARCEL 2 - 0000 Xxxxxxx Xxxxxxxxx - Police Station: (APN: 025-010-21-100) All that portion of Section 3, Township 12 North, Range 18 East, M.D.M., more particularly described as follows: Beginning at the corner common to Lots 1, 2 and 14 of said Section 3; thence along the lot line common to Lot 2 and Lot 14 South 89°26’11” West, 695.04 feet to a point of cap at a non-tangent curve from which the center bears South 30°11’22” West, 640.00 feet; thence Southeasterly along said curve through a central angle of 25°42’14” an arc distance 287.12 feet; thence tangent to said curve South 34°06’24” East, 108.00 feet; thence North 89°26’11” East, 617.42 feet; thence North 18°37’15” East, 303.22 feet to a point on the lot line common to Lot 1 and Lot 14; thence South 89°26’11” West, 287.86 feet to the point of beginning. PARCEL 4 - 1176 Xxxxx Xxxxx - Xxxxxxx Xxxx (APN: 026-050-004) [APN may change with land swap but a new one has not been assigned yet] All that certain real property situate in Lot 1 of Section 32, Township 13 North, Range 18 East, Mount Diablo Meridian, Cou...
Sample 1
Financing Authority. A. Establishment. Recognizing the interstate nature of the CWIP and the capabilities of the SRBC as an interstate agency that works throughout the Susquehanna River Basin, the Parties agree that the SRBC will serve as the financing authority for initial implementation of the CWIP, as approved by the Signatory CWIP Partners. The SRBC’s role as the financing authority will sunset on December 31, 2025, with the option for renewal. Whether or not the option for renewal is exercised, funded ongoing or approved projects shall continue until completion or funds are exhausted, whichever occurs first.
Sample 1
Financing Authority the Xxxxxx County Industrial Facilities and Pollution Control Financing Authority. GAAP: with respect to Granutec, generally accepted accounting principles as in effect in the United States and with respect to Novopharm and Xxxxxxx, generally accepted accounting principles as in effect in Canada.
Sample 1
Financing Authority. Applicants propose to engage in the transactions described below from time to time, as applicable, through June 30, 2005.
Sample 1
AutoNDA by SimpleDocs
Financing Authority. [ATTEST] By: ---------------------------- ------------------------------------- Secretary, Board of Commissioners Chairman, Board of Commissioners HARRXX XXXST AND SAVINGS BANK, AS TRUSTEE By: /s/ -------------------------- TRUST OFFICER [INDENTURE OF TRUST DATED AS OF NOVEMBER 1, 1995]
Sample 1

Related to Financing Authority

  • Contracting authority The contracting authority of this public contract is Enabel, the Belgian development agency, public-law company with social purposes, with its registered office at Xxx Xxxxx 000, 0000 Xxxxxxxx xx Xxxxxxx (enterprise number 0264.814.354, RPM/RPR Brussels). Enabel has the exclusive competence for the execution, in Belgium and abroad, of public service tasks of direct bilateral cooperation with partner countries. Moreover, it may also perform other development cooperation tasks at the request of public interest organisations, and it can develop its own activities to contribute towards realisation of its objectives. For this procurement contract, Xxxxxx is represented by person(s) who shall sign the award letter and are mandated to represent the organisation towards third parties.

  • Decision-Making Authority BMS shall have the sole decision-making authority for the operations and Commercialization strategies and decisions, including funding and resourcing, related to the Commercialization of Products; provided that such decisions are not inconsistent with the express terms and conditions of this Agreement, including BMS’ diligence obligations set forth in Section 5.1.

  • Signing Authority Will the above-named Partner be able to sign contracts on behalf of the Partnership? ☐ Yes ☐ No Partner 2: with a mailing address of . a.) Ownership: %

  • Regulatory Authority If any regulatory authority having jurisdiction (or any successor boards or agencies), a court of competent jurisdiction or other Governmental Authority with the appropriate jurisdiction (collectively, the ''Regulatory Body'') issues a rule, regulation, law or order that has the effect of cancelling, changing or superseding any term or provision of this Agreement (the ''Regulatory Requirement''), then this Agreement will be deemed modified to the extent necessary to comply with the Regulatory Requirement. Notwithstanding the foregoing, if a Regulatory Body materially modifies the terms and conditions of this Agreement and such modification(s) materially affect the benefits flowing to one or both of the Parties, as determined by either of the Parties within twenty (20) business days of the receipt of the Agreement as materially modified, the Parties agree to attempt in good faith to negotiate an amendment or amendments to this Agreement or take other appropriate action(s) so as to put each Party in effectively the same position in which the Parties would have been had such modification not been made. In the event that, within sixty (60) days or some other time period mutually agreed upon by the Parties after such modification has been made, the Parties are unable to reach agreement as to what, if any, amendments are necessary and fail to take other appropriate action to put each Party in effectively the same position in which the Parties would have been had such modification not been made, then either Party shall have the right to unilaterally terminate this Agreement forthwith.

  • Appointing Authority If the grievance is not settled under Step 1, it may be formally submitted to the appointing authority. The grievance shall be submitted within seven (7) days after receipt of the written decision from Step 2 or the verbal decision of Step 1, whichever applies. Within seven (7) days after receipt of the written grievance, the appointing authority or designated representative shall meet with the employee. Within seven (7) days thereafter, a written decision shall be delivered to the employee.

  • Regulatory Authorities Except as described in the Registration Statement, the General Disclosure Package or the Prospectus, each of the Company and its subsidiaries: (a) is and at all times has been in material compliance with all statutes, rules or regulations applicable to the ownership, testing, development, manufacture, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product manufactured or distributed by the Company (“Applicable Laws”); (b) has not received any FDA Form 483, notice of adverse finding, warning letter, untitled letter or other correspondence or notice from the FDA or any other federal, state or foreign governmental authority having authority over the Company (“Governmental Authority”) alleging or asserting material noncompliance with any Applicable Laws or any licenses, certificates, approvals, clearances, authorizations, permits and supplements or amendments thereto required by any such Applicable Laws (“Authorizations”); (c) possesses all Authorizations and such Authorizations are valid and in full force and effect and are not in material violation of any term of any such Authorizations; (d) has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any Governmental Authority or third party alleging that any product, operation or activity is in violation of any Applicable Laws or Authorizations and have no knowledge that any such Governmental Authority or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding; (e) has not received notice that any Governmental Authority has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorizations and has no knowledge that any such Governmental Authority is considering such action; and (f) has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were materially complete and correct on the date filed (or were corrected or supplemented by a subsequent submission). The studies, tests and preclinical and clinical trials material to the Company and its subsidiaries taken as a whole, and conducted by or on behalf of the Company and each of its subsidiaries, were and, if still pending, are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional scientific standards and all Applicable Laws and Authorizations, including, without limitation, the Federal Food, Drug and Cosmetic Act and implementing regulations at 21 C.F.R. Parts 50, 54, 56, 58 and 312; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the General Disclosure Package or the Prospectus are accurate and complete in all material respects and fairly present the data derived from such studies, tests and trials; except to the extent disclosed in the Registration Statement, the General Disclosure Package or the Prospectus, the Company is not aware of any studies, tests or trials the results of which the Company believes reasonably call into question the study, test, or trial results described or referred to in the Registration Statement, the General Disclosure Package or the Prospectus when viewed in the context in which such results are described and the clinical state of development; and neither the Company nor any of its subsidiaries has received any notices or correspondence from any Governmental Authority requiring the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company or any of its subsidiaries that are material to the Company and its subsidiaries taken as a whole.

  • General Authority of the Collateral Agent By acceptance of the benefits of this Agreement and any other Collateral Documents, each Secured Party (whether or not a signatory hereto) shall be deemed irrevocably (a) to consent to the appointment of the Collateral Agent as its agent hereunder and under such other Collateral Documents, (b) to confirm that the Collateral Agent shall have the authority to act as the exclusive agent of such Secured Party for the enforcement of any provisions of this Agreement and such other Collateral Documents against any Grantor, the exercise of remedies hereunder or thereunder and the giving or withholding of any consent or approval hereunder or thereunder relating to any Collateral or any Grantor’s obligations with respect thereto, (c) to agree that it shall not take any action to enforce any provisions of this Agreement or any other Collateral Document against any Grantor, to exercise any remedy hereunder or thereunder or to give any consents or approvals hereunder or thereunder except as expressly provided in this Agreement or any other Collateral Document and (d) to agree to be bound by the terms of this Agreement and any other Collateral Documents.

  • Other Regulatory Approvals All necessary approvals, authorizations and consents of any governmental or regulatory entity required to consummate the Merger shall have been obtained and remain in full force and effect, and all waiting periods relating to such approvals, authorizations and consents shall have expired or been terminated.

  • Proper Authority Each Party represents and warrants that the person executing this Grant Agreement on its behalf has full power and authority to enter into this Grant Agreement.

  • Developer Authority Consistent with Good Utility Practice and this Agreement, the Developer may take whatever actions or inactions with regard to the Large Generating Facility or the Developer Attachment Facilities during an Emergency State in order to (i) preserve public health and safety, (ii) preserve the reliability of the Large Generating Facility or the Developer Attachment Facilities, (iii) limit or prevent damage, and (iv) expedite restoration of service. Developer shall use Reasonable Efforts to minimize the effect of such actions or inactions on the New York State Transmission System and the Connecting Transmission Owner’s Attachment Facilities. NYISO and Connecting Transmission Owner shall use Reasonable Efforts to assist Developer in such actions.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!